Clinical trial
A Retrospective Study Investigating Survival for High-grade Osteosarcoma Patients Who Had Achieved First Complete Surgical Remission (SCR) During Combined-modality Therapy in Two Hospitals Affiliated to Peking University
NCT04546243 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Study Investigating Survival for High-grade Osteosarcoma Patients Who Had Achieved First Complete Surgical Remission (SCR) During Combined-modality Therapy in Two Hospitals Affiliated to Peking University
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- November 1, 2020
- Enrollment
- 127 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
osteosarcoma metastatic, pulmonary disease, resectable sarcoma, survival